Related Experiment Video
Updated: May 11, 2026

HOX Loci Focused CRISPR/sgRNA Library Screening Identifying Critical CTCF Boundaries
Published on: March 31, 2019
SPOP-mediated K27-linked non-degradative ubiquitination of KCNN3 suppressing HCC progression via the CTCF-SATB1 axis
Ziqing Zhan1,2, Yidong Ge1, Jiaxin Shi1
1Department of Biochemistry and Molecular Biology, Health Science Center, Ningbo University, Ningbo, China.
Abstract:
The metastasis of hepatocellular carcinoma (HCC) cells remains a major obstacle to achieving favorable clinical outcomes, yet the underlying molecular mechanisms are still not fully understood. The dysregulation of ion channels is related to epithelial-mesenchymal transition (EMT) phenotype-related pathways, especially the aberrant function of K+ ion channels in HCC. In this study, we observed that the potassium-calcium-activated channel subfamily N member 3 (KCNN3/SK3/ KCa2.3) ion channels were significantly upregulated in HCC cells, promoting the migration and invasion of HCC in vitro and in vivo. Mechanistically, activation of the KCNN3 ion channel was found to enhance phosphorylation of the CCCTC-binding factor (CTCF), which in turn stimulates transcription of the EMT-related factor special AT-rich sequence-binding protein 1 (SATB1) via binding the "CCCTC" region within its promoter, thereby driving HCC cell migration and invasion. Furthermore, we identified that speckle-type POZ protein (SPOP), an E3 ligase adaptor, recognizes the SPOP-binding consensus (SBC) motif "ASSTT" (aa 250-254) in KCNN3 and mediates its ubiquitination via K27-linked ubiquitin chain. Notably, this type of ubiquitination does not induce KCNN3 turnover, but induced KCNN3 translocation from the cell membrane into the cytosol, thus suppressing KCNN3-mediated ion channel activity. Importantly, HCC-associated SPOP mutations or KCNN3-ΔSBC dramatically disrupt the SPOP-KCNN3 regulatory axis, accelerating HCC progression. These effects can be effectively counteracted by treatment with the KCNN3 channel inhibitor edelfosine and the calcium chelators BAPTA-AM, suggesting a promising therapeutic strategy for HCC patients.
Insights
Hepatocellular carcinoma (HCC) cell migration is promoted by upregulated potassium-calcium-activated channel subfamily N member 3 (KCNN3). SPOP regulates KCNN3 activity, and its disruption accelerates HCC progression, offering therapeutic targets.
Area of Science:
- Oncology
- Molecular Biology
- Ion Channel Physiology
Background:
- Metastasis of hepatocellular carcinoma (HCC) is a significant clinical challenge.
- Dysregulation of ion channels, particularly K+ channels, is implicated in HCC's epithelial-mesenchymal transition (EMT).
Purpose of the Study:
- To elucidate the role of potassium-calcium-activated channel subfamily N member 3 (KCNN3) in HCC metastasis.
- To investigate the molecular mechanisms linking KCNN3, CCCTC-binding factor (CTCF), special AT-rich sequence-binding protein 1 (SATB1), and speckle-type POZ protein (SPOP) in HCC progression.
Main Methods:
- Quantitative analysis of KCNN3 expression in HCC cells.
- In vitro and in vivo assays for cell migration and invasion.
- Western blotting and immunoprecipitation to study protein interactions and modifications.
- Analysis of SPOP-KCNN3 ubiquitination and KCNN3 translocation.
- Assessment of therapeutic interventions using KCNN3 inhibitors and calcium chelators.
Main Results:
- KCNN3 ion channels are significantly upregulated in HCC cells, promoting migration and invasion.
- KCNN3 activation enhances CTCF phosphorylation, upregulating SATB1 transcription and driving HCC cell motility.
- Speckle-type POZ protein (SPOP) recognizes KCNN3, mediating K27-linked ubiquitination that translocates KCNN3 intracellularly, suppressing its activity.
- HCC-associated SPOP mutations or KCNN3 alterations disrupt this regulatory axis, accelerating HCC progression.
Conclusions:
- The KCNN3 ion channel is a key driver of HCC metastasis through the CTCF-SATB1 pathway.
- SPOP-mediated regulation of KCNN3 activity is crucial for controlling HCC progression.
- Targeting KCNN3 with inhibitors like edelfosine or calcium chelators presents a potential therapeutic strategy for HCC.
Related Concept Videos
Anaphase Promoting Complex
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
Canonical Wnt Signaling Pathway
Inhibition of Cdk Activity
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

